Ruxolitinib, CAS 941678-49-5

JAK kinase inhibitor

Product Type: Inhibitor

CAS No.: 941678-49-5

MolecularFormula: C17H18N6

Molecular Weight: 306,4

Source: Synthetic

Purity: >98%

Solubility: Soluble in DMSO (25 mg/ml) or EtOH (~15 mg/ml)

Appearance: Off-white solid

PubChem CID: 25126798

Scientific Background: Ruxolitinib is a Janus-associated kinases (JAK) inhibitor, which specifically inhibits JAK1 and JAK3. JAKs are known to active the signaling of certain growth factor receptors and cytokines.

References: 1. Aittomäki S., & Pesu M. (2014) Basic & Clin. Pharm.Toxic. 114(1): 18–23.

Field of Use: Not for use in humans. Not for use in diagnostics or therapeutics. For in vitro research use only.

• Artikelnummer: STRSIH-509-25MG
• Hersteller: Stressmarq Biosciences
• Hersteller Artikelnummer: SIH-509-25MG
• Green Labware: Nein
• Verpackungseinheit: 25 mg
• Mengeneinheit: STK